Axsome Therapeutics, Inc.

📍 New York, United States🗓 Founded 2012👥 450 employees💰 Last funded Aug 2020
Biotechnology Research🌐 axsome.com
Website LinkedIn
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians.
3
Total investors
2
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
United Kingdom
1
Investor activity1992–2020 · investors recorded per year
199212014120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. has 3 investors on record on gritt.io, including 2 early-stage backers and 1 late-stage investors.
When did Axsome Therapeutics, Inc. last raise funding?
The most recent investment in Axsome Therapeutics, Inc. recorded on gritt.io was in August 2020.
When was Axsome Therapeutics, Inc. founded?
Axsome Therapeutics, Inc. was founded in 2012.
What industry is Axsome Therapeutics, Inc. in?
Axsome Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Axsome Therapeutics, Inc. based?
Axsome Therapeutics, Inc. is headquartered in New York, United States.